Robert Zweigerdt

Jun 15, 2024 | mdpi.com | Anja Schneider |Axel Hage |Nils Kriedemann |Robert Zweigerdt

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Nov 3, 2023 | cellandgene.com | Felix Manstein |Kevin Ullmann |Robert Zweigerdt

By Felix Manstein, Kevin Ullmann, and Robert Zweigerdt Human induced pluripotent stem cells (hiPSCs) are a powerful tool for innovative approaches, such as drug discovery, in vitro disease modelling, or regenerative therapies. The DASbox® Mini Bioreactors and the DASbox Mini Bioreactor System have been tested to demonstrate their ability to systematically optimize the process parameters of a hiPSC culture in a step-by-step process.

Oct 5, 2023 | bioprocessonline.com | Felix Manstein |Kevin Ullmann |Robert Zweigerdt

By Felix Manstein, Kevin Ullmann, and Robert Zweigerdt Human induced pluripotent stem cells (hiPSCs) are a powerful tool for innovative approaches, such as drug discovery, in vitro disease modelling, or regenerative therapies. The DASbox® Mini Bioreactors and the DASbox Mini Bioreactor System have been tested to demonstrate their ability to systematically optimize the process parameters of a hiPSC culture in a step-by-step process.